Clinical Trials

NCT05202951 | ACTIVE_NOT_RECRUITING
350 participants

Chronic Pain and Hemophilia

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-29
Start Date:
2022-02-28
Completion:
2025-12-18
Conditions
  • Chronic Pain
  • Hemophilia
Interventions
  • OTHER
No Results Yet
NCT05201833 | ACTIVE_NOT_RECRUITING
300 participants

TRACK-TBI Longitudinal Biomarker Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-29
Start Date:
2022-03-01
Completion:
2026-06-30
Conditions
  • Traumatic Brain Injury
Interventions
  • BEHAVIORAL
  • PROCEDURE
No Results Yet
NCT05185947 | COMPLETED | PHASE2
21 participants

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2022-10-13
Completion:
2025-01-27
Conditions
  • Gynecologic Cancer
  • Gynecologic Neoplasms
  • Peritoneal Carcinomatosis
  • Peritoneal Neoplasms
  • Ovarian Cancer
  • Ovarian Neoplasms
  • Colorectal Cancer
  • Colorectal Neoplasms
  • Appendiceal Cancer
  • Appendiceal Neoplasms
  • Cholangiocarcinoma
  • Breast Cancer
Interventions
  • DRUG
  • DIAGNOSTIC_TEST
  • PROCEDURE
NCT05058651 | RECRUITING | PHASE2/PHASE3
189 participants

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2022-06-28
Completion:
2028-10-01
Conditions
  • Advanced Extrapulmonary Neuroendocrine Carcinoma
  • Metastatic Extrapulmonary Neuroendocrine Carcinoma
  • Recurrent Extrapulmonary Neuroendocrine Carcinoma
  • Unresectable Extrapulmonary Neuroendocrine Carcinoma
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page